Literature DB >> 35088226

Adverse effects of deoxycholic acid in submandibular glands, submental, inguinal and subplantar regions: a study in rats.

Gabriela Alacarini Farina1, Valesca Sander Koth1, Fábio Luiz Dal Moro Maito2, Márcia Rodrigues Payeras2, Karen Cherubini1, Fernanda Gonçalves Salum3.   

Abstract

OBJECTIVE: We aimed to evaluate the effects of the deoxycholic acid (DCA) in the submental and subplantar regions of rats, and to histologically analyze the changes caused in the submandibular glands, soft tissues of the paw, and inguinal adipose tissue.
MATERIAL AND METHODS: Sixty male Wistar rats were divided into DCA and control (CG) groups. DCA was injected in the submental, inguinal, and subplantar regions, and saline was injected in the CG. The animals were euthanized after 24 h and at 7 and 21 days.
RESULTS: The DCA group showed edema in the submental region in 24 h and in the paw in all experimental times. In the paw there were also erythema and ulceration in 7 days, and alopecia after 21 days. At 21 days, a few animals also showed erythema and ulceration in paw; however, there was no significant difference from CG. Histological analysis of the paw showed an intense inflammatory process, with a predominance of neutrophils, lymphocytes, and plasma cells in 24 h and 7 days. In the adipose tissue, we observed loss of architecture and inflammatory infiltrate, followed with a lower number of adipose cells, and at 21 days, fibroplasia. In the submandibular glands we observed inflammatory infiltration, loss of tissue architecture, and fibrosis.
CONCLUSIONS: DCA produces a significant inflammatory process in the structures. It can cause skin ulcerations and, in salivary glands, it causes loss of tissue architecture and fibrosis. CLINICAL RELEVANCE: There has been growing increase in the use of DCA for aesthetic purposes by health care providers. Due to the presence of important anatomical structures in the submental region, constant vigilance is required to report new adverse effects.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Adipose tissue; Deoxycholic acid; Side effects; Submandibular gland; Submental fat

Mesh:

Substances:

Year:  2022        PMID: 35088226     DOI: 10.1007/s00784-021-04227-6

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  21 in total

1.  ATX-101 for reduction of submental fat: A phase III randomized controlled trial.

Authors:  Shannon Humphrey; Jonathan Sykes; Jonathan Kantor; Vince Bertucci; Patricia Walker; Daniel R Lee; Paul F Lizzul; Todd M Gross; Frederick C Beddingfield
Journal:  J Am Acad Dermatol       Date:  2016-07-16       Impact factor: 11.527

2.  Efficacy and safety of ATX-101 as a treatment for submental fullness: A retrospective analysis of two aesthetic practices.

Authors:  Misha Zarbafian; Mahsa Karavan; Ryan Greene; Sabrina Guillen Fabi
Journal:  J Cosmet Dermatol       Date:  2019-09-25       Impact factor: 2.696

3.  Submental Alopecia at Deoxycholic Acid Injection Site.

Authors:  Brittany Grady; Fernanda Porphirio; Cameron Rokhsar
Journal:  Dermatol Surg       Date:  2017-08       Impact factor: 3.398

Review 4.  The development, evidence, and current use of ATX-101 for the treatment of submental fat.

Authors:  Corey Georgesen; Shari R Lipner
Journal:  J Cosmet Dermatol       Date:  2017-04-21       Impact factor: 2.696

Review 5.  ATX-101 (deoxycholic acid injection) for reduction of submental fat.

Authors:  Benjamin Ascher; Jere Fellmann; Gary Monheit
Journal:  Expert Rev Clin Pharmacol       Date:  2016-08-18       Impact factor: 5.045

6.  A phase 1 pharmacokinetic study of ATX-101: serum lipids and adipokines following synthetic deoxycholic acid injections.

Authors:  Patricia Walker; Daniel Lee
Journal:  J Cosmet Dermatol       Date:  2015-02-14       Impact factor: 2.696

7.  ATX-101 (Deoxycholic Acid Injection) Leads to Clinically Meaningful Improvement in Submental Fat: Final Data From CONTOUR.

Authors:  Kathleen Behr; Carmen M Kavali; Girish Munavalli; Craig F Teller; Steve Yoelin; Laura Breshears; Sara Sangha
Journal:  Dermatol Surg       Date:  2020-05       Impact factor: 3.398

8.  Effect of a Formulation Containing Low-Dose Sodium Deoxycholate on Local Fat Reduction.

Authors:  Sang Hoon Park; Mi Ri Hyun; Sang Wha Kim
Journal:  Aesthetic Plast Surg       Date:  2019-10-09       Impact factor: 2.326

9.  Lipomas treated with subcutaneous deoxycholate injections.

Authors:  Adam M Rotunda; Glynis Ablon; Michael S Kolodney
Journal:  J Am Acad Dermatol       Date:  2005-10-19       Impact factor: 11.527

Review 10.  Deoxycholic Acid (ATX-101) for Reduction of Submental Fat.

Authors:  Kaelen C Dunican; Dhiren K Patel
Journal:  Ann Pharmacother       Date:  2016-06-23       Impact factor: 3.154

View more
  1 in total

1.  Primary stability of different implant macrodesigns in a sinus floor elevation simulated model: an ex vivo study.

Authors:  Mikio Imai; Yoichiro Ogino; Hideaki Tanaka; Kiyoshi Koyano; Yasunori Ayukawa; Takeshi Toyoshima
Journal:  BMC Oral Health       Date:  2022-08-08       Impact factor: 3.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.